Exploratory Science Center

Researchers Discover New Model for "Global" DNA Repair

Retrieved on: 
Wednesday, March 30, 2022

NEW YORK, March 30, 2022 /PRNewswire/ -- Two studies provide a radically new picture of how bacterial cells continually repair damaged sections (lesions) in their DNA.

Key Points: 
  • Given that damaged DNA can result in detrimental DNA code changes (mutations) and death, cells evolved to have DNA repair machineries.
  • Widely accepted work, including studies that led to a 2015 Noble Prize , had argued that TCR played a relatively small role in repair because it relied on a putative TCR factor that made only a marginal contribution to DNA repair.
  • A parallel process, global genome repair (GGR), was assumed to scan and fix most of DNA independent of transcription.
  • Both processes were thought to set the stage for nucleotide excision repair (NER), in which a damaged stretch of DNA was snipped out and replaced by an accurate copy.

DGAP-News: Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm

Retrieved on: 
Wednesday, September 22, 2021

Laupheim and Ulm, Germany, September 22, 2021 - Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is donating 50,000 Euros to support the creation of the Albert Einstein Discovery Center.

Key Points: 
  • Laupheim and Ulm, Germany, September 22, 2021 - Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is donating 50,000 Euros to support the creation of the Albert Einstein Discovery Center.
  • Dr. Frank Mathias, CEO of Rentschler Biopharma SE; Alexander Dettmer, CFO; and Dr. Christian Schetter, CSO, presented a check to Dr. Nancy Hecker-Denschlag, Chairwoman of the Albert Einstein Discovery Center Ulm e.V.
  • The construction of the Albert Einstein Discovery Center, therefore, is an excellent occasion to create educational opportunities in our region.
  • In Stevenage, UK, Rentschler Biopharma has launched a company dedicated to cell and gene therapies, Rentschler ATMP Ltd.
    About the Albert Einstein Discovery Center Ulm e.V.